Scholarlink

<p>Microbial biotransformation of three bioactive phenolic constituents from <i>Aframomum melegueta</i> K. schum, namely 6-gingerol, 6-paradol and 6-shogaol, was performed by <i>Bacillus subtilis</i> 168, <i>Pseudomonas aeruginosa</i> PO1A and <i>Candida albicans</i> ATCC10231. Structures of the isolated compounds were determined using LC/MS analyses<i>.</i> To assess and compare their potential nephroprotective effects, the parent compounds and their biotransformation metabolites were subjected to molecular docking studies targeting AMP-activated protein kinase (AMPK) for the first time. During microbial biotransformation, a series of reactions, primarily hydroxylation and reduction, were observed, resulting in the identification of five distinct metabolites. LC/MS analysis of the fermentation medium revealed that <i>Bacillus subtilis</i> 168 converted 6-gingerol into 6-gingerdiol (M1) and hydroxylated 6-gingerol (M2), while 6-shogaol was transformed into 6-paradol (M3) and hydroxylated 6-shogaol (M4). Additionally, 6-paradol underwent further reduction to form (M5). Docking results showed that all compounds demonstrated binding affinity to AMPK, indicating potential nephroprotective activity. Notably, M1 exhibited the highest binding affinity, suggesting its strong therapeutic promise as a nephroprotective agent of natural origin. M5 ranked second in binding affinity, followed by M4. These results highlight the effectiveness of microbial transformation in generating bioactive derivatives with potentially enhanced biological activity compared to their natural precursors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

In silico nephroprotective evaluation of microbial biotransformed metabolites from Aframomum melegueta

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月22日

查看全文
  • Rabab Mahrous Abdou,
  • Riham Salah El-Dine,
  • Reham Samir,
  • Nebal Darwish El-Tanbouly,
  • Aly Mohamed El-Sayed

摘要

Microbial biotransformation of three bioactive phenolic constituents from Aframomum melegueta K. schum, namely 6-gingerol, 6-paradol and 6-shogaol, was performed by Bacillus subtilis 168, Pseudomonas aeruginosa PO1A and Candida albicans ATCC10231. Structures of the isolated compounds were determined using LC/MS analyses. To assess and compare their potential nephroprotective effects, the parent compounds and their biotransformation metabolites were subjected to molecular docking studies targeting AMP-activated protein kinase (AMPK) for the first time. During microbial biotransformation, a series of reactions, primarily hydroxylation and reduction, were observed, resulting in the identification of five distinct metabolites. LC/MS analysis of the fermentation medium revealed that Bacillus subtilis 168 converted 6-gingerol into 6-gingerdiol (M1) and hydroxylated 6-gingerol (M2), while 6-shogaol was transformed into 6-paradol (M3) and hydroxylated 6-shogaol (M4). Additionally, 6-paradol underwent further reduction to form (M5). Docking results showed that all compounds demonstrated binding affinity to AMPK, indicating potential nephroprotective activity. Notably, M1 exhibited the highest binding affinity, suggesting its strong therapeutic promise as a nephroprotective agent of natural origin. M5 ranked second in binding affinity, followed by M4. These results highlight the effectiveness of microbial transformation in generating bioactive derivatives with potentially enhanced biological activity compared to their natural precursors.